{
  "docId": "019de50e-d292-716f-9ce2-d72fb83a57c0",
  "docSlug": "bede1f03edbb16951b81551a4f6eebab",
  "documentTitle": "Theranos | Investor Conference Presentation Deck | 88 slides",
  "authorId": "theranos",
  "authorName": "Theranos",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2016-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 46,
  "pageCount": 88,
  "prevPage": 45,
  "nextPage": 47,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide outlines the clinical study parameters for a Herpes diagnostic test.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de50e-d292-716f-9ce2-d72fb83a57c0/46",
  "deckHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0",
  "deckJsonHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0.json",
  "deckAnchorHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0#slide-46",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "This technology has not been cleared or approved by the FDA and is not for sale in the United States.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "67155017-c984-49fd-8211-28f995db7e7d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.94,
        "x": 0.03,
        "y": 0.23
      },
      "kind": "table",
      "text": "Population: At risk for Herpes (intended use population); Samples type and matrix: Venous serum; Comparator: Focus HerpesSelect 1 & 2 Immunoblot; Number of miniLabs: 7; Study design: CLSI EP12-A2; Analysis: Compute negative and positive percent agreement compared to comparative method",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63926c6a-9205-4f38-b500-f45c6c30af8c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.78,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Immunochemistry: Method Comparison Study Overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58da3162-0697-476e-9347-d5b57d9717ce",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "analytical-method",
      "slug": null,
      "matchId": "b4b2aa0c-5825-45cd-b543-9e634d083f4c",
      "evidence": "The slide details the specific clinical study design (CLSI EP12-A2) and methodology for validating a diagnostic test.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 51,
      "from": 42,
      "beatId": "e3d72853-2715-472a-b512-d65254411975",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Complication",
      "beatSlug": "complication",
      "evidence": "The document highlights the challenges and limitations of current laboratory testing processes",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}